Vanderbilt Research Trending Archives
‘Audacious’ grant spurs research on retina regeneration
Sep. 1, 2016—Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina.
New center will examine addiction at molecular level, develop treatments
Aug. 17, 2016—Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.
NIH grant bolsters mass spectrometry research initiatives
Aug. 11, 2016—The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine.
Team explores transcription factor’s autoimmunity role
Aug. 11, 2016—Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently.
Vanderbilt and Human Vaccines Project launch initial studies to decode the human immune system
Jun. 21, 2016—Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human “immunome,” the genetic underpinnings of the immune system.
Study shows opioids increase risk of death when compared to other pain treatments
Jun. 14, 2016—Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA).
Improving natural killer cancer therapy
Apr. 29, 2016—A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies.
Study explores how some breast cancers resist treatment
Apr. 21, 2016—A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.
Kennedy Center joins nation’s largest autism study
Apr. 21, 2016—The Vanderbilt Kennedy Center (VKC) is one of a select group of sites selected to launch SPARK, an online research initiative designed to become the largest autism study ever undertaken in the United States.
Study suggests cancer’s ‘clock’ can be rewound
Mar. 17, 2016—Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.
Vanderbilt researchers identify potential antibody treatment for H7 avian flu
Mar. 7, 2016—Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.
Sleep research for parents of children with ASD expanded
Feb. 25, 2016—The expansion of sleep education sessions through a research study will allow more parents to learn effective sleep strategies for children with autism spectrum disorder.
